Clinical response to a single-dose methylphenidate challenge is indicative of treatment response at two months in adults with ADHD
Stimulants such as methylphenidate (MPH) are the first-line pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD). Although stimulants are effective at a group level, individual response varies, which advocates for tailored treatment…
Suggested reading